Amlenetug contre l'atrophie multisystématisée

from La biblio Neuro · host Dr Nicolas Landragin

Cette source présente les résultats d'un essai clinique de phase 2, nommé AMULET, portant sur l'amlenetug, un anticorps monoclonal conçu pour traiter l'atrophie multisystématisée.Kjærsgaard L, Wiedemann J, Singer W, Takeda A, Berger AK, Flensburg MF, et al. Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial. Lancet Neurol. 2026Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Jun 4, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Amlenetug contre l'atrophie multisystématisée

0:00 5:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of La biblio Neuro?

This episode is 5 minutes long.

When was this La biblio Neuro episode published?

This episode was published on June 4, 2026.

Can I download this La biblio Neuro episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!